GENE ONLINE|News &
Opinion
Blog

AbbVie
AbbVie Boosts Global Manufacturing with $223 Million Expansion in Singapore
2024-01-29
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
New Data Shows the Long Term Effectiveness of AbbVie’s Psoriatic Arthritis Treatment
2022-09-12
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
Compensating for OxyContin: The Harm from Pharma
2022-04-12
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
1 2
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top